Our Services

The Hemophilia Treatment Center of Nevada provides these services (and others) at both locations.  For specific questions or concerns please contact the HTC directly.

  • Diagnostic Evaluations for Hemophilia A and B
  • Diagnostic Evaluations for Von Willebrand Disease
  • Diagnostic Evaluations for Rare Bleeding Disorders
  • Comprehensive Clinics
  • 340 B Drug Discount Program
  • Pharmacy
  • Annual Comprehensive Physicals
  • Clinical Trials for New Therapies
  • Coordination for Primary Care Physician
  • Emergency Consultations
  • Hematologic Management for Surgeries, Dental Procedures and Childbirth
  • Transfusion Services (at home and in the clinic)
  • Patient and Family Education
  • Social Work Assistance with Complex Diseases

Our Providers


Amber Federizo, RN, MSN, FNP-BC

Amber is a bit of a rarity–she’s a native Nevadan who grew up in rural Nevada in towns such as Eureka, Carson City, and Fallon, NV. She is an alumni of the University of Nevada, Reno and was able to complete her education thanks to the support of scholarships provided by Nevadans for Nevadans such as the Millenium and Pennington scholarships. She is grateful to have the opportunity to  return the gift by providing medical care to the community which supported her.

Looking back, it’s probably not a huge surprise she went into medicine.  As she points out, as a child she can remember playing alongside her brother with Legos and keeping Lego men alive in elaborate brick hospitals until such time as the rest of their body pieces could be found or they fully recovered. (As it turns out her brother would always build things like police cars, and he’s now a police officer!)

Amber is especially grateful to provide medical services and expertise to those in rural areas.  She understands how difficult it can be  to access even basic medical care for those living several hours away from a metropolitan area. She is among those from the Hemophilia Treatment Center who travel several times a year to provide on site clinics for those with inherited bleeding disorders in areas which include Winnemucca, the Owyhee Indian community, Ely and Elko. Clinics in Reno are held more frequently occurring about twice a month. Her love of Nevada and its residents runs deep.

She adds: “I plan on running with the pack (University of Nevada, Reno representing Northern Nevada) and living with the rebels (University of Nevada, Las Vegas representing Southern Nevada) to ensure all Nevadans with bleeding disorders are cared for.”


Las Vegas

3121 S. Maryland Parkway (Near Desert Inn)
Suite #205
Las Vegas, NV  89109

(702) 732-1956   
Toll Free: 1-877-732-1956  
Fax (702) 732-1080


540 West Plumb Lane,
Suite #200, Reno, NV 89509

(775) 657-8981  
Toll Free: 1-877-732-1956   
Fax (775) 657-8317

Patient Forms

Current and new patients! We are updating our system and need all established and new patients to fill out and submit this form prior to your next appointment:


This is a study of Hemophilia Treatment Center patients, demographics and health services from 1990 to 2010 courtesy of  the journal Haemophilia.

Summary. For several decades, US government agencies have partially supported regional networks of Hemophilia Treatment Centers (HTC). HTC multidisciplinary teams provide comprehensive and coordinated diagnosis, treatment, prevention, education, outreach and surveillance services to improve the health of people with genetic bleeding disorders. However, national data are scarce on HTC-patient population trends and services. The aim of the study was to examine national trends over the past 20 years in patient diagnoses, demographics and health services utilization among the Health Resources and Services Administration (HRSA) and Centers for Disease Control and Prevention (CDC)-supported HTC network. Diagnoses, demographics and health services utilization data from 1990 to 2010 were aggregated from all HTCs using the Hemophilia Data Set (HDS). From 1990 to 2010, the HTC population grew 90%from 17 177 to 32 612. HTC patients with von Willebrand’s disease increased by 148%, females by 346%, Hispanic patients by 236%and African Americans by 104%. Four thousand and seventyfive deaths were reported. From 2002 to 2010, annual comprehensive evaluations grew 38%, and persons with severe haemophilia on a home intravenous therapy programme rose 37%. In 2010, 46%of patients were less than 18 years vs. 24%for the general US population. The Hemophilia Data Set documents the growth and diversity of the US Hemophilia Treatment Center Network’s patient population and services. Despite disproportionate deaths due toHIV, theHTC patient base grew faster than the general US population. The HDS is a vital national public health registry for this rare-disorder population.

Full Study: HDS Trends

Contact Hemophilia Treatment Center.

Please fill out this form